Listed

Bolt Biotherapeutics, Inc.: Form SCHEDULE 13D/A, filed Feb 26, 2026

Filed with the SEC on Feb 26, 2026 and accepted by EDGAR at Feb 26, 2026, 19:22 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001012975-26-000212. Last ingested by Listed: Nov 13, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.